Clinical impact of predictive assays for acute and late radiation morbidity.
BACKGROUND
Clinically reliable predictive assays for normal tissue radiation sensitivity would help to avoid severe radiation induced morbidity and result in individualized dose prescriptions. Profound differences of individual fibroblast and lymphocyte radiation sensitivity in vitro have been documented in patients with certain genetic syndromes but also in patients without known genetic disorders. The following review evaluates whether fibroblast or lymphocyte radiation sensitivity measured in vitro correlates with the degree of acute and late radiation induced morbidity.


RESULTS
Acute radiation side effects and lymphocyte sensitivity has been investigated in 2 studies. One of them reported an insecure correlation, the other no correlation at all. Fibroblast radiation sensitivity and the extent of acute radiation induced side effects on skin and mucosal sites has been compared in a total of 5 studies. None of these studies found a consistent significant correlation. Lymphocyte radiation sensitivity and late effects have been studied by 2 institutions. Late radiation induced skin and mucosal changes did not correlate with lymphocyte sensitivity in head and neck cancer patients, whereas in breast cancer patients a weak (R2 = 0.06) correlation between the degree of late skin reactions and lymphocyte sensitivity was observed. Late skin or mucosal radiation reactions and fibroblast sensitivity were examined by 5 research groups. Data analysis revealed significant correlations or at least a trend towards a significant correlation in all studies. The quality of the reported correlations expressed as R2 ranged from 0.13 to 0.60, indicating a low predictive value.


CONCLUSIONS
Lymphocyte radiation sensitivity as measured by currently available assays does not or only poorly correlate with acute and late effects of radiation in patients, precluding predictive tests based on lymphocyte sensitivity. Fibroblast radiation sensitivity does not correlate with acute but generally correlates with late radiation morbidity. The quality of the later correlation is insufficient for a reliable predictive test with currently available methods to determine cellular radiation sensitivity.
Budach
W
W
Abteilung für Strahlentherapie, Eberhard-Karls-Universität Tübingen. Wilfried.Budach@Uni-Tuebingen.de
Classen
J
J
Belka
C
C
Bamberg
M
M
D001943:Breast Neoplasms / Q000532:radiotherapy; D005260:Female; D005347:Fibroblasts / Q000528:radiation effects; D005500:Follow-Up Studies; D006801:Humans; D009017:Morbidity; D011237:Predictive Value of Tests; D011832:Radiation Injuries / Q000453:epidemiology* / Q000503:physiopathology; D011836:Radiation Tolerance; D011878:Radiotherapy / Q000009:adverse effects*; D012044:Regression Analysis; D012307:Risk Factors; D013997:Time Factors